A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients

Clinical trial NCT01656525 · COMPLETED

Trial details

NCT number: NCT01656525
Sponsor: Chugai Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2012-06-01
Primary completion: 2014-03-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.